Literature DB >> 32458429

Turkish version of the Pregnancy-related Anxiety Scale: A psychometric study.

Gonul Kurt1, Hamide Arslan2.   

Abstract

PURPOSE: To adapt the Pregnancy-related Anxiety Scale (PrAS) into Turkish and evaluate its psychometric properties. DESIGN AND METHODS: This cross-sectional study comprised of 400 pregnant women. The PrAS was translated using the methods of translation, back-translation, consensus meetings, and a trial of potential users. Then, its psychometric properties were evaluated by exploratory factor analysis and confirmatory factor analysis.
FINDINGS: The PrAS consists of 33 items. Following the exploratory factor analysis, the two items in the scale were discarded because factor loads were less than 0.50, therefore, the number of items decreased from 33 to 31. In the confirmatory factor analysis, the goodness-of-fit indices of the scale were found to be suitable. The internal consistency coefficient calculated for the reliability of the scale was .89. After correlating it with another scale for measuring pregnancy distress, the Turkish version of the PrAS shows discriminant validity. PRACTICE IMPLICATIONS: The Turkish version of the PrAS is a valid and reliable instrument that can be used to evaluate pregnancy-related-anxiety. The use of the PrAS in prenatal healthcare services will contribute to the early diagnosis, treatment, and management of pregnancy-related anxiety.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  pregnancy-related anxiety; reliability; scale; validity

Mesh:

Year:  2020        PMID: 32458429     DOI: 10.1111/ppc.12537

Source DB:  PubMed          Journal:  Perspect Psychiatr Care        ISSN: 0031-5990            Impact factor:   2.186


  1 in total

1.  Measurement of pregnancy-related anxiety worldwide: a systematic review.

Authors:  Kristin Hadfield; Samuel Akyirem; Luke Sartori; Abdul-Malik Abdul-Latif; Dominic Akaateba; Hamideh Bayrampour; Anna Daly; Kelly Hadfield; Gilbert Abotisem Abiiro
Journal:  BMC Pregnancy Childbirth       Date:  2022-04-15       Impact factor: 3.105

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.